Microsaic Systems | GenomeWeb

Microsaic Systems

NEW YORK (GenomeWeb) – Microsaic Systems and Plexus today announced an agreement for the commercial manufacturing of Microsaic's 4000MiD miniature mass spectrometry system.

NEW YORK (GenomeWeb News) – Miniature mass spectrometry firm Microsaic Systems today reported that revenues for the first half of the year doubled year over year.

With $7 million in new funding, instrument firm 908 Devices is preparing to launch sales of its first miniature mass spec platform in early 2014.

NEW YORK (GenomeWeb News) – UK miniaturized mass spectrometry platform development company Microsaic Systems today announced that revenues more than doubled year over year during the first half of 2012.
The company also announced the appointment of Colin Jump as its new CEO.

NEW YORK (GenomeWeb News) – UK miniature mass spectrometry firm Microsaic Systems today announced a conditional placing of about 3.9 million shares to raise £1.6 million ($2.5 million).

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories disclosed in its 10-Q filed this week that during the first quarter it acquired certain assets from a current raw material supplier for around $12.5 million.

NEW YORK (GenomeWeb News) – Miniaturized mass spectrometry firm Microsaic Systems today announced preliminary results of £267,999 ($432,463) in revenues and a £1.9 million loss for full-year 2011.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Miniaturized mass spectrometry firm Microsaic Systems today announced that its revenues for the first half of 2011 fell 35 percent year over year, while losses increased 30 percent.

The UK firm which went public last month has developed an instrument about the size of a PC targeting laboratories, both small and large, that may not have the space for a conventional platform.

The company said it is the first and only firm to have successfully miniaturized mass specs, using its patented chip-based technology.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.